Browse by People

Collapse authors list.
Coakley, Maria ORCID: 0000-0003-2658-7789, Villacampa, Guillermo ORCID: 0000-0003-4868-6585, Sritharan, Prithika ORCID: 0009-0004-9733-3596, Swift, Claire ORCID: 0009-0003-6974-2926, Dunne, Kathryn ORCID: 0009-0007-7259-744X, Kilburn, Lucy ORCID: 0000-0002-1987-7545, Goddard, Katie ORCID: 0009-0006-6682-4418, Pipinikas, Christodoulos ORCID: 0009-0007-7310-167X, Rojas, Patricia ORCID: 0000-0003-4298-731X, Emmett, Warren ORCID: 0009-0002-4739-1515 et al (show 14 more authors) , Hall, Peter ORCID: 0000-0001-6015-7841, Harper-Wynne, Catherine ORCID: 0000-0002-8414-6722, Hickish, Tamas ORCID: 0000-0001-6770-7279, Macpherson, Iain ORCID: 0000-0003-4295-8885, Okines, Alicia ORCID: 0000-0002-2068-2593, Wardley, Andrew ORCID: 0000-0002-9639-0888, Wheatley, Duncan ORCID: 0000-0002-1919-5114, Waters, Simon ORCID: 0000-0003-0205-4398, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Winter, Matthew ORCID: 0000-0001-6192-9874, Cutts, Rosalind J ORCID: 0000-0002-8297-9341, Garcia-Murillas, Isaac ORCID: 0000-0001-8183-7969, Bliss, Judith ORCID: 0000-0001-7957-7424 and Turner, Nicholas C ORCID: 0000-0001-8937-0873 (2024) Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 30 (4). pp. 895-903.

Collapse authors list.
Jones, Robert P ORCID: 0000-0001-5608-001X, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A et al (show 92 more authors) , Cunningham, David, Wadsley, Jonathan, Darby, Suzanne, Meyer, Tim, Gillmore, Roopinder, Anthoney, Alan, Lind, Pehr, Glimelius, Bengt, Falk, Stephen, Izbicki, Jakob R, Middleton, Gary William, Cummins, Sebastian, Ross, Paul J, Wasan, Harpreet, McDonald, Alec, Crosby, Tom, Ting, Yuk, Patel, Kinnari, Sherriff, David, Soomal, Rubin, Borg, David, Sothi, Sharmila, Hammel, Pascal, Lerch, Markus M, Mayerle, Julia, Tjaden, Christine, Strobel, Oliver, Hackert, Thilo, Buchler, Markus W, Neoptolemos, John P, Hill, Mark, Corrie, Pippa, Hickish, Tamas, Napier, Mark, Slater, Sarah, Valle, Juan, Shablak, Alaaeldin, Cunnell, Michelle, Guimbaud, Rosine, Roques, Tom, Iveson, Tim, Jamil, Arshad, Robinson, Angus, Garcia-Alonso, Angel, Chang, David, Tsang, David, Wadd, Nick, Wall, Lucy, Nielsen, Niels Hilmer, Lerch, Markus, Mehta, Ajay, Sivaramalingam, Muthiah, Fyfe, David, Osborne, Richard, Blesing, Claire, Bulusu, Venkata Ramesh, Rathbone, Emma, Seitz, Jean-Francois, Beaumont, Erica, Dernedde, Ulrike, McAdam, Karen, Dimopoulos, Prokopios, Cominos, Mathilda, Askill, Colin, Piwowar, Andrzej, Bachet, Jean-Baptiste, Sumpter, Kate, Raouf, Sherif, Nicoll, Jonathan, Rees, Charlotte, Dhinakaran, Kathirvelu, Haux, Johan, Bengrine-Lefevre, Leila, Terrebonne, Eric, Shankland, Catherine, Palmer, Cheryl, Medley, Louise, Toy, Elizabeth, Kaur, Jasvinder, Gupta, Kamalnayan, Cheeseman, Sue, Patterson, Daniel, Candish, Charles, Thompson, Joyce, Coxon, Fareeda, Connolly, Caroline, McPhail, Neil, Williams, Rachel, Flygare, Petra, Elmlund, Mattias, Artru, Pascal and Millat, Bertrand (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154 (11). pp. 1038-1048.

Collapse authors list.
Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony ORCID: 0000-0001-8547-1730, Shaw, Victoria E ORCID: 0000-0002-0429-0186, Wadsley, Jonathan, Valle, Juan W et al (show 14 more authors) , Propper, David, Wasan, Harpreet, Falk, Stephen, Cunningham, David, Coxon, Fareeda, Ross, Paul, Madhusudan, Srinivasan, Wadd, Nick, Corrie, Pippa, Hickish, Tamas, Costello, Eithne, Campbell, Fiona, Rawcliffe, Charlotte and Neoptolemos, John P (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18 (4). pp. 486-499.